Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
29 studies found for:    " December 05, 2012":" January 04, 2013"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" December 05, 2012":" January 04, 2013"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Active, not recruiting An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis
Condition: HIV Infection
Interventions: Behavioral: 3MV;   Behavioral: PCC;   Drug: Emtricitabine/tenofovir (FTC/TDF (Truvada®))
2 Completed Project ACCEPT: Engaging Newly Diagnosed HIV+ Youth in Care
Condition: HIV Positive Youth That Are Newly Engaged in Care
Interventions: Behavioral: Project ACCEPT;   Behavioral: HEALTH
3 Withdrawn The Feasibility of Using a General Health Screen to Increase HIV Testing in Community Pharmacies
Condition: HIV Infections
Interventions: Behavioral: HIV Test Offer;   Behavioral: General Health Screen Offer
4 Completed Folinic Acid and Vascular Reactivity in HIV
Condition: Human Immunodeficiency Virus (HIV) Infection
Interventions: Dietary Supplement: Folinic Acid;   Other: Placebo
5 Completed Alcohol Harm Reduction Intervention Among Female Sex Workers in Mombasa, Kenya
Condition: Alcohol Use and STI/HIV Infections, Domestic Violence
Intervention: Behavioral: Behavioral Intervention for Alcohol Use
6 Completed Vitamin D Absorption in HIV Infected Young Adults Being Treated With Tenofovir Containing cART
Condition: HIV Infection
Interventions: Dietary Supplement: Vitamin D3 50,000 IU;   Dietary Supplement: Vitamin D3 placebo
7 Active, not recruiting Behavioral Intervention to Enhance HIV Test/Treat
Condition: HIV/AIDS
Interventions: Behavioral: Infectiousness Risk Reduction;   Behavioral: General Health Improvement
8 Active, not recruiting Promoting Antiretroviral Therapy Among Serodiscordant Couples to Reduce HIV Transmission
Condition: HIV
Intervention: Behavioral: comprehensive intervention components
9 Recruiting Evaluating the Safety, Tolerance, and Pharmacokinetics of a Raltegravir-Containing Antiretroviral Therapy (ART) Regimen in Children Infected With HIV and TB
Conditions: HIV Infections;   Tuberculosis
Intervention: Drug: Raltegravir
10 Completed Randomized Control Trial of Shang Ring Versus Forceps-guided Adult Male Circumcision in Southwestern Uganda.
Condition: HIV
Interventions: Procedure: Shang Ring Guided Circumcision;   Procedure: Forceps Guided Circumcision
11 Completed Veterans Living With HIV/AIDS: A Pilot Study Examining Risk Factors Associated With Self-Directed Violence
Conditions: Human Immunodeficiency Virus Infection(HIV)/Acquired Immunodeficiency Syndrome (AIDS);   Self-Directed Violence
Intervention:
12 Active, not recruiting Palliative Care in People Living With HIV/AIDS: Integrating Into Standard of Care
Condition: HIV
Interventions: Behavioral: FAmily-CEntered Advance Care Planning;   Behavioral: Healthy Living Control
13 Completed Pharmacokinetic Interactions Between Telaprevir and Un-boosted Atazanavir
Conditions: Hepatitis C, Chronic;   HIV Infection
Interventions: Drug: Ritonavir withdrawal, atazanavir 200 mg/12h;   Drug: Telaprevir interactions
14 Completed A Randomized Study to Assess the Relative Bioavailability of New Formulations of GSK1265744 Long Acting Parental (LAP) in Healthy Adult Subjects
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: GSK1265744 30 mg oral;   Drug: Midazolam 3 mg oral + GSK1265744 30mg oral;   Drug: GSK1265744 400 mg (200 nm);   Drug: GSK1265744 400 mg (1 micro m);   Drug: GSK1265744 400 mg (5 micro m)
15 Unknown  Rosuvastatin to Decrease Residual Immune Activation in HIV Infection
Condition: HIV-1 Infection
Intervention: Drug: Rosuvastatin 20 mg/day
16 Unknown  Assessment of Cognitive Functioning as it Relates to Risk for Suicide in Veterans With HIV/AIDS
Condition: Veterans With HIV/AIDS Diagnosis.
Intervention:
17 Recruiting Does Rosuvastatin Delay Progression of Atherosclerosis in HIV
Conditions: HIV;   Cardiovascular Disease
Interventions: Drug: Rosuvastatin;   Other: Placebo
18 Completed Evaluating the Effect of a Novel Web-based Intervention to Increase HIV Testing in Men Who Have Sex With Men
Condition: HIV Testing
Interventions: Behavioral: Online HIV testing motivational videos and messages sent via mobile-phone text messaging, e-mail or instant messaging;   Behavioral: Standard online message with an invitation for free HIV testing similar in content to other Peruvian websites
19 Completed A Muli-Center, Open-Label, Randomized, Two-Period, Crossover Non-Inferiority Trial
Condition: Human Immunodeficiency Virus
Intervention: Device: Female condom
20 Completed
Has Results
Atorvastatin for HAART Suboptimal Responders
Condition: Acquired Immune Deficiency Syndrome Virus
Interventions: Other: atorvastatin, Lipitor®;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-29) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.